Zhejiang East Asia Pharmaceutical Co., Ltd.SSE: 605177

Semi-annual Performance Forecast for 2026

· Issued by Zhejiang East Asia Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 3 pages · Chinese

Summary by 6ix AI

The company anticipates a net profit attributable to shareholders in the range of negative values, reflecting a significant decline compared to the previous year. The company is implementing strategies to enhance market presence and product offerings despite these difficulties.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Zhejiang East Asia Pharmaceutical Co., Ltd. on 6ix

Earlier from Zhejiang East Asia Pharmaceutical

Later from Zhejiang East Asia Pharmaceutical

All Zhejiang East Asia Pharmaceutical news releases